CDC45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.547400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.867400E-01
Normal-vs-Stage2
3.448800E-01
Normal-vs-Stage3
3.987400E-01
Normal-vs-Stage4
6.308800E-01
Stage1-vs-Stage2
5.235600E-01
Stage1-vs-Stage3
8.793600E-01
Stage1-vs-Stage4
6.569000E-01
Stage2-vs-Stage3
6.867400E-01
Stage2-vs-Stage4
4.053800E-01
Stage3-vs-Stage4
5.313600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.618800E-01
Normal-vs-AfricanAmerican
3.300200E-01
Normal-vs-Asian
1.553950E-01
Caucasian-vs-AfricanAmerican
1.503600E-01
Caucasian-vs-Asian
8.274400E-01
AfricanAmerican-vs-Asian
2.638400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.580800E-01
Normal-vs-Female
3.845000E-01
Male-vs-Female
1.728180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.821600E-01
Normal-vs-Age(41-60Yrs)
4.778200E-01
Normal-vs-Age(61-80Yrs)
2.139400E-01
Normal-vs-Age(81-100Yrs)
9.403900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.995200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.296390E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.031500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.631200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.558000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.472200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.270000E-01
Normal-vs-Daily Drinker
2.838400E-01
Normal-vs-Weekly Drinker
1.283610E-01
Normal-vs-Occasional Drinker
2.625400E-01
Normal-vs-Social Drinker
2.265200E-01
Non Drinker-vs-Daily Drinker
4.697000E-01
Non Drinker-vs-Weekly Drinker
3.840600E-01
Non Drinker-vs-Occasional Drinker
8.090200E-01
Non Drinker-vs-Social Drinker
5.623000E-01
Daily Drinker-vs-Weekly Drinker
2.914000E-01
Daily Drinker-vs-Occasional Drinker
3.996400E-01
Daily Drinker-vs-Social Drinker
9.385200E-01
Weekly Drinker-vs-Occasional Drinker
4.345400E-01
Weekly Drinker-vs-Social Drinker
3.001400E-01
Occasional Drinker-vs-Social Drinker
4.810600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.295200E-01
Normal-vs-Grade 2
5.488200E-01
Normal-vs-Grade 3
5.539600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.020100E-02
Grade 1-vs-Grade 3
2.307500E-02
Grade 1-vs-Grade 4
5.295200E-01
Grade 2-vs-Grade 3
5.448600E-01
Grade 2-vs-Grade 4
5.488200E-01
Grade 3-vs-Grade 4
5.539600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.518600E-01
Normal-vs-NonDiabetic
3.709000E-01
Diabetic-vs-NonDiabetic
4.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.572500E-02
Normal-vs-NoPancreatitis
4.081000E-01
Pancreatitis-vs-NoPancreatitis
3.393200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.125600E-01
Normal-vs-N1
3.791400E-01
N0-vs-N1
9.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.581500E-03
Normal-vs-TP53-NonMutant
2.437600E-01
TP53-Mutant-vs-TP53-NonMutant
8.041300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
